The Obesity Drug Revolution: New Frontiers in Pharmacotherapy. [PDF]
Manoria PC.
europepmc +1 more source
Depressive disorders: systematic review of approved psychiatric medications (2009-April 2025) and pipeline phase 3 medications. [PDF]
IsHak WW +15 more
europepmc +1 more source
Fixed dose combination dextromethorphan-bupropion: A hope for treatment resistant depression (TRD). [PDF]
Das R +3 more
europepmc +1 more source
Diverse Obesity Trajectories in a Family Including Identical Twins with a Pathogenic <italic>MC4R</italic> Variant. [PDF]
Lim JJX, Hooper AJ, Khoo J, Loh WJ.
europepmc +1 more source
Korean Medication Algorithm for Depressive Disorder 2025, Fifth Revision: An Executive Summary. [PDF]
Kim NY +18 more
europepmc +1 more source
Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trial. [PDF]
Saidi AN +10 more
europepmc +1 more source
Clozapine plasma level toxicity induced by a pharmacokinetic interaction with bupropion: A case report. [PDF]
Gable KN, Asher J.
europepmc +1 more source
Smoking cessation in India: A narrative review. [PDF]
Singh A, Kishore K.
europepmc +1 more source

